Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic ... Concomitant use of anticholinergic drugs with Gvoke VialDx is not recommended.

Produced by the German company Boehringer Ingelheim, alongside Zealand Pharma, Survodutide is an injectable drug that activates both the glucagon and GLP-1 receptors. According to Nature, the drug is ...

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic ... successfully with existing and new drugs, and its and collaborators’ ability to protect ...